Healthcare provider profile · identity verified

Dan E Mccarty, DO

Family Practice · WICHITA, KS · NPI 1780641613

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	422	106
Levothyroxine Sodium	Levothyroxine Sodium	317	80
Amlodipine Besylate	Amlodipine Besylate	274	74
Lisinopril	Lisinopril	268	71
Rosuvastatin Calcium	Rosuvastatin Calcium	225	63
Omeprazole	Omeprazole	208	60
Escitalopram Oxalate	Escitalopram Oxalate	191	35
Losartan Potassium	Losartan Potassium	185	50
Potassium Chloride	Potassium Chloride	180	47
Gabapentin	Gabapentin	179	39
Pantoprazole Sodium	Pantoprazole Sodium	129	31
Tamsulosin Hcl	Tamsulosin Hcl	127	31
Hydrochlorothiazide	Hydrochlorothiazide	121	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	117	27
Metformin Hcl Er	Metformin Hcl	117	30
Meloxicam	Meloxicam	114	39
Metformin Hcl	Metformin Hcl	105	28
Simvastatin	Simvastatin	105	27
Furosemide	Furosemide	103	28
Allopurinol	Allopurinol	99	26
Duloxetine Hcl	Duloxetine Hcl	87	16
Clopidogrel	Clopidogrel Bisulfate	84	22
Metoprolol Tartrate	Metoprolol Tartrate	82	19
Albuterol Sulfate Hfa	Albuterol Sulfate	79	26
Trazodone Hcl	Trazodone Hcl	79	14
Tramadol Hcl	Tramadol Hcl	78	17
Donepezil Hcl	Donepezil Hcl	77	21
Carvedilol	Carvedilol	76	21
Alendronate Sodium	Alendronate Sodium	75	19
Metoprolol Succinate	Metoprolol Succinate	74	18
Ozempic	Semaglutide	72	suppressed
Sertraline Hcl	Sertraline Hcl	69	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	18
Tizanidine Hcl	Tizanidine Hcl	61	13
Tresiba Flextouch U-100	Insulin Degludec	60	suppressed
Citalopram Hbr	Citalopram Hydrobromide	54	16
Pravastatin Sodium	Pravastatin Sodium	54	16
Xarelto	Rivaroxaban	53	suppressed
Eliquis	Apixaban	50	suppressed
Jardiance	Empagliflozin	50	suppressed
Ezetimibe	Ezetimibe	49	11
Fentanyl	Fentanyl	49	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	13
Synthroid	Levothyroxine Sodium	49	suppressed
Fluticasone Propionate	Fluticasone Propionate	48	suppressed
Bumetanide	Bumetanide	47	11
Tresiba Flextouch U-200	Insulin Degludec	46	suppressed
Warfarin Sodium	Warfarin Sodium	46	11
Baclofen	Baclofen	44	12
Prednisone	Prednisone	44	29
Mirtazapine	Mirtazapine	42	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	42	11
Synjardy	Empagliflozin/Metformin Hcl	42	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	41	34
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Atenolol	Atenolol	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	32
Januvia	Sitagliptin Phosphate	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	suppressed
Famotidine	Famotidine	33	suppressed
Celecoxib	Celecoxib	32	suppressed
Myrbetriq	Mirabegron	31	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Finasteride	Finasteride	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Amoxicillin	Amoxicillin	26	15
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Diazepam	Diazepam	23	suppressed
Hysingla Er	Hydrocodone Bitartrate	23	suppressed
Valsartan	Valsartan	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Methenamine Hippurate	Methenamine Hippurate	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Azithromycin	Azithromycin	19	15
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Primidone	Primidone	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Cefdinir	Cefdinir	13	12
Estradiol	Estradiol	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Belsomra	Suvorexant	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Topiramate	Topiramate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error